The Accuracy of 6 Inexpensive Pulse Oximeters Not Cleared by the Food and Drug Administration: The Possible Global Public Health Implications
The Accuracy of 6 Inexpensive Pulse Oximeters Not Cleared by the Food and Drug Administration: The Possible Global Public Health Implications
复制标题
DOI:
10.1213/ane.0000000000001300
复制
发表时间:
2016-08-01
影响因子:
5.7
通讯作者:
Bickler, Philip E.
中科院分区:
文献类型:
--
作者:
Lipnick, Michael S.;Feiner, John R.;Bickler, Philip E.
BACKGROUND: Universal access to pulse oximetry worldwide is often limited by cost and has substantial public health consequences. Low-cost pulse oximeters have become increasingly available with limited regulatory agency oversight. The accuracy of these devices often has not been validated, raising questions about performance.METHODS: The accuracy of 6 low-cost finger pulse oximeters during stable arterial oxygen saturations (Sao(2)) between 70% and 100% was evaluated in 22 healthy subjects. Oximeters tested were the Contec CMS50DL, Beijing Choice C20, Beijing Choice MD300C23, Starhealth SH-A3, Jumper FPD-500A, and Atlantean SB100 II. Inspired oxygen, nitrogen, and carbon dioxide partial pressures were monitored and adjusted via a partial rebreathing circuit to achieve 10 to 12 stable target Sao2 plateaus between 70% and 100% and Paco(2) values of 35 to 45 mm Hg. Comparisons of pulse oximeter readings (Spo(2)) with arterial Sao(2) (by Radiometer ABL90 and OSM3) were used to calculate bias (Spo(2) - Sao(2)) mean, precision (SD of the bias), and root mean square error (ARMS).RESULTS: Pulse oximeter readings corresponding to 536 blood samples were analyzed. Four of the 6 oximeters tested showed large errors (up to -6.30% mean bias, precision 4.30%, 7.53 ARMS) in estimating saturation when Sao2 was reduced